Erythema multiforme - Erythema Ioma-Chruth
☆ AI Dermatology — Free Service
Ann an toraidhean 2022 Stiftung Warentest às a’ Ghearmailt, cha robh sàsachd luchd-cleachdaidh le ModelDerm ach beagan nas ìsle na le co-chomhairlean telemedicine pàighte.
Ann an toraidhean 2022 Stiftung Warentest às a’ Ghearmailt, cha robh sàsachd luchd-cleachdaidh le ModelDerm ach beagan nas ìsle na le co-chomhairlean telemedicine pàighte.
Erythema multiforme minor ― Thoir an aire gun faod ionadan nan lòthan a dhol a-mach.
Faodar urticaria a mheas cuideachd mar dhearbhadh eadar‑dhealaichte.
relevance score : -100.0%
ReferencesTha Erythema multiforme (EM) na chumha far a tha spotan sònraichte coltach ri targaid a’ nochdadh air an dà chuid a’ chraicinn agus air na membranan mucous mar thoradh air ath-bhualaidhean dìonachd. Ged a tha e tric air a bhrosnachadh le galair bhìorais viral, gu sònraichte bhìoras herpes simplex (HSV), no le cuid de chungaidhean leigheis, tha an adhbhar fhathast neo-aithnichte ann an iomadh cùis. Le bhith a’ làimhseachadh EM aig a’ chiad bhuidheann, tha am fòcas air lughdachadh nan comharraidhean le cleachdadh uachdaran a tha a’ toirt a-steach steroids no antihistamines. Tha riaghladh EM ath-chuairteach nas èifeachdaiche nuair a thèid e a dhealbhadh airson gach euslaintich. Tha dòighean-obrach tùsail a’ toirt a-steach làimhseachadh beòil agus làitheil, nam measg corticosteroids agus cungaidhean anti-bhìorais. Tha làimhseachadh cùis a’ gabhail a-steach uachdaran steroid làidir agus fuasglaidhean a tha a’ buaidh air na membranan mucous. Airson euslaintich nach eil a’ freagairt air anti-bhìorasan, tha roghainnean eile a’ gabhail a-steach drogaichean dìon, antibiotics, anthelmintics agus antimalarials.
Erythema multiforme (EM) is an immune-mediated condition that classically presents with discrete targetoid lesions and can involve both mucosal and cutaneous sites. While EM is typically preceded by viral infections, most notably herpes simplex virus (HSV), and certain medications, a large portion of cases are due to an unidentifiable cause. Treatment for acute EM is focused on relieving symptoms with topical steroids or antihistamines. Treatment for recurrent EM is most successful when tailored to individual patients. First line treatment for recurrent EM includes both systemic and topical therapies. Systemic therapies include corticosteroid therapy and antiviral prophylaxis. Topical therapies include high-potency corticosteroids, and antiseptic or anesthetic solutions for mucosal involvement. Second-line therapies for patients who do not respond to antiviral medications include immunosuppressive agents, antibiotics, anthelmintics, and antimalarials
Erythema multiforme (EM) is an immune-mediated condition that classically presents with discrete targetoid lesions and can involve both mucosal and cutaneous sites. While EM is typically preceded by viral infections, most notably herpes simplex virus (HSV), and certain medications, a large portion of cases are due to an unidentifiable cause. Treatment for acute EM is focused on relieving symptoms with topical steroids or antihistamines. Treatment for recurrent EM is most successful when tailored to individual patients. First line treatment for recurrent EM includes both systemic and topical therapies. Systemic therapies include corticosteroid therapy and antiviral prophylaxis. Topical therapies include high-potency corticosteroids, and antiseptic or anesthetic solutions for mucosal involvement. Second-line therapies for patients who do not respond to antiviral medications include immunosuppressive agents, antibiotics, anthelmintics, and antimalarials
Ann an iomadh suidheachadh, bidh erythema multiforme tlàth a’ falbh leis fhèin taobh a-staigh 2 gu 4 seachdainean. Faodaidh an syndrome Stevens-Johnson, droch staid a bheir buaidh air fileagan mucous, mairsinn suas ri 6 seachdainean. Mar as trice, chan eil e air a mholadh steroids airson cùisean tlàth. Chan eil cinnteach co-dhiù a bu chòir steroids a chleachdadh airson erythema multiforme trom, leis nach eil toraidhean soilleir ann bho sgrùdaidhean air thuaiream a 'sealltainn dè a' chlann a gheibheadh buannachd bhon leigheas seo.
In most cases, mild erythema multiforme is self-limited and resolves in 2 to 4 weeks. Stevens-Johnson syndrome is a serious disease that involves the mucous membranes and lasts up to 6 weeks. There is no indication for using steroids for the mild form. Use of steroids for erythema multiforme major is debatable because no randomized studies clearly indicate which children will benefit from this treatment.
In most cases, mild erythema multiforme is self-limited and resolves in 2 to 4 weeks. Stevens-Johnson syndrome is a serious disease that involves the mucous membranes and lasts up to 6 weeks. There is no indication for using steroids for the mild form. Use of steroids for erythema multiforme major is debatable because no randomized studies clearly indicate which children will benefit from this treatment.
Bidh sinn a’ taisbeanadh cùis de erythema multiforme (EM) beòil air adhbhrachadh le TMP/SMX, a’ sealltainn ulcair beòil is bilean àbhaisteach gun lochran craiceann. Tha seo a’ daingneachadh an fheum air leigheas bho eas-òrdughan beul-aithris eile. Fhuair an euslaintich làimhseachadh samhlachail le prednisolone, a leantainn gu leasachadh às deidh stad a chuir air an leigheas le TMP/SMX.
We report a case of oral erythema multiforme (EM) secondary to TMP/SMX that presented with oral and lip ulcerations typical of EM without any skin lesions and highlights the importance of distinguishing them from other ulcerative disorders involving oral cavity. The patient was treated symptomatically and given tablet prednisolone. The condition improved with stoppage of TMP/SMX therapy.
We report a case of oral erythema multiforme (EM) secondary to TMP/SMX that presented with oral and lip ulcerations typical of EM without any skin lesions and highlights the importance of distinguishing them from other ulcerative disorders involving oral cavity. The patient was treated symptomatically and given tablet prednisolone. The condition improved with stoppage of TMP/SMX therapy.
Tha Erythema multiforme na fhreagairt a tha a’ toirt a-steach a’ chraiceann agus, uaireannan, am mucosa, a phobrachadh leis an t‑siostam dìon. Mar as trice, bidh e a’ nochdadh mar leòintean coltach ri targaid, a dh’fhaodadh a bhith aonaranach, a’ tighinn air ais no a’ leantainn. Mar as trice bidh na leòintean sin a’ toirt buaidh cho‑chothromach air na h‑iomaill, gu sònraichte an uachdar a‑muigh. Am measg nam prìomh adhbharan tha galairean leithid bhìoras herpes simplex agus Mycoplasma pneumoniae, a bharrachd air cuid de chungaidhean leigheis, banachd, agus galairean fèin‑dhìon. Tha eadar-dhealachadh eadar erythema multiforme agus urticaria a tha ri fhaicinn fad nan lotan; tha leòintean erythema multiforme a’ mairsinn co‑dhiù seachd latha, fhad ’s a tha lotan urticaria gu tric a’ fàs ann am latha. Ged a tha iad coltach, tha e deatamach eadar erythema multiforme agus an t‑sìdeamra Stevens‑Johnson nas cruaidhe, a bhios mar as trice a’ toirt a-steach maculan erythematous no purpuric le blisters. Tha riaghladh erythema multiforme a’ gabhail a-steach faochadh samhlachail le steroids gnàthach no antihistamines agus dèiligeadh ris a’ bhun‑adhbhar. Airson cùisean ath‑chur le bhìoras herpes simplex, tha sinn a’ moladh leigheas anti‑viral prophylactic. Dh’fhaodadh gum feum air fìor dhroch cheangal mucosal airson ospadal, le lionntan intravenals agus ath‑chur electrolytean.
Erythema multiforme is a reaction involving the skin and sometimes the mucosa, triggered by the immune system. Typically, it manifests as target-like lesions, which may appear isolated, recur, or persist. These lesions usually symmetrically affect the extremities, particularly their outer surfaces. The main causes include infections like herpes simplex virus and Mycoplasma pneumoniae, as well as certain medications, immunizations, and autoimmune diseases. Distinguishing erythema multiforme from urticaria relies on the duration of lesions; erythema multiforme lesions remain fixed for at least seven days, while urticarial lesions often vanish within a day. Although similar, it's crucial to differentiate erythema multiforme from the more severe Stevens-Johnson syndrome, which typically presents widespread erythematous or purpuric macules with blisters. Managing erythema multiforme involves symptomatic relief with topical steroids or antihistamines and addressing the underlying cause. For recurrent cases associated with herpes simplex virus, prophylactic antiviral therapy is recommended. Severe mucosal involvement may necessitate hospitalization for intravenous fluids and electrolyte replacement.
Erythema multiforme is a reaction involving the skin and sometimes the mucosa, triggered by the immune system. Typically, it manifests as target-like lesions, which may appear isolated, recur, or persist. These lesions usually symmetrically affect the extremities, particularly their outer surfaces. The main causes include infections like herpes simplex virus and Mycoplasma pneumoniae, as well as certain medications, immunizations, and autoimmune diseases. Distinguishing erythema multiforme from urticaria relies on the duration of lesions; erythema multiforme lesions remain fixed for at least seven days, while urticarial lesions often vanish within a day. Although similar, it's crucial to differentiate erythema multiforme from the more severe Stevens-Johnson syndrome, which typically presents widespread erythematous or purpuric macules with blisters. Managing erythema multiforme involves symptomatic relief with topical steroids or antihistamines and addressing the underlying cause. For recurrent cases associated with herpes simplex virus, prophylactic antiviral therapy is recommended. Severe mucosal involvement may necessitate hospitalization for intravenous fluids and electrolyte replacement.
Tha an suidheachadh ag atharrachadh bho bhroth tlàth, fèin‑chuingealaichte, gu cruth cruaidh a tha a’ bagairt air beatha, ris an canar erythema multiforme major, a tha cuideachd a’ toirt a-steach fileagan mucous. Tha ionnsaigh air a’ membran mucous no làthaireachd bullaes nan comharran cudromach de dhragh.
- Erythema multiforme minor: targaidean àbhaisteach no àrdaichte, papules edematous air an sgaoileadh gu h‑acraileach.
Mar as trice bidh an cruth tlàth a’ nochdadh beagan tachas (ach faodaidh tachas a bhith gu math dona), blotches pinc‑dearg, a tha air an rèiteachadh gu co‑chothromach agus a’ tòiseachadh air na h‑oirean. Tha fuasgladh na brotha taobh a-staigh 7–10 latha mar an àbhaist anns an fhoirm seo den ghalar.
- Erythema multiforme major: targaidean àbhaisteach no àrdaichte, papules edematous air an cuairteachadh gu h‑acraileach le com‑pàirt aon no barrachd membran mucous. Tha sgaradh epidermal a’ toirt a-steach nas lugha na 10 % de raon uachdar iomlan a’ chùirp.
○ Làimhseachadh – OTC Drugs
Ma tha fiabhras ann (teòthachd bodhaig a’ èirigh), thathas a’ moladh tadhal air an ospadal cho luath ’s a ghabhas.
Bu chòir stad a chur air drogaichean a tha fo amharas (m.e. antibiotics, drogaichean neo‑steroidal anti‑inflammatory).
Antihistamines beòil leithid cetirizine agus loratadine airson tachas fhèin.
#Cetirizine [Zytec]
#LevoCetirizine [Xyzal]
#Loratadine [Claritin]